| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | US20040143867 High level production of p-hydroxybenzoic acid in green plants |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040142861 at least one genetically-engineered growth factor, at least one genetically-engineered antioxidant, at least one genetically-engineered extracellular matrix component |
| 07/22/2004 | US20040141984 Amyloid beta 1-6 antigen arrays |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/21/2004 | EP1438325A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 07/21/2004 | EP1437937A2 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor |
| 07/21/2004 | EP1223958A4 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514878A Method for detecting calpain 3 activity in biological sample and peptides for implementsing said method |
| 07/21/2004 | CN1513878A Antitumour medicine containing recombination bacterial toxin protein complex substance |
| 07/21/2004 | CN1513877A Artificial combined antistaphylococcus engineering multipeptide and its preparation method |
| 07/21/2004 | CN1158387C Chimeric gene encoding antigenic determinants of four proteins of L.INFANTUM |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004012673A3 Methods and reagents relating to inflammation and apoptosis |
| 07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | US20040138421 ACPL DNA and polypeptides |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138419 Inhibitor of cell proliferation and methods of use thereof |
| 07/15/2004 | US20040138417 Chimeric heteromultimer adhesins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137590 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 07/15/2004 | US20040136907 Compounds with binding affinity for both alpha v beta 3 and somatostatin receptors; arginine, glycine, aspartic acid; improved overall affinity for tumors |
| 07/15/2004 | CA2774928A1 Binding agents which inhibit myostatin |
| 07/14/2004 | EP1437414A2 A method for promoting biocatalyst diversity |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/08/2004 | WO2004035622A3 Antagonists il-15 |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2002095058A3 Emission ratiometric indicators of phosphorylation |
| 07/08/2004 | US20040132972 Tri-hybrid melanoma antigen |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |
| 07/08/2004 | US20040132180 Expression vector coding reporter protein for use as diagnostic tool in gene transformation analysis |
| 07/08/2004 | US20040132094 Combinatorial libraries of proteins having the scaffold structure of c-type lectinlike domains |
| 07/08/2004 | US20040132093 Comprises cytokine receptor fusion protein for use in indentifying modulators for treatment of bone disorders |
| 07/08/2004 | US20040132075 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 07/08/2004 | US20040132052 Comprises nucleotide sequences coding cell signaling glycoprotein for use in screening and identifying antagonist of cancer; tumor diagnosis and treatment; antitumor agents; drug screening |
| 07/08/2004 | US20040132007 Modified virus |
| 07/08/2004 | US20040131589 Materials and methods for inhibition of IgE production |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434483A2 NUCLEIC ACIDS ENCODING LINKED CHROMO/FLUORESCENT DOMAINS AND METHODS FOR USING THE SAME |
| 07/07/2004 | EP1387884A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1156573C Process for preparing fusion protein used for glucose sensor |
| 07/06/2004 | US6759520 Containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia; used for the treatment of pain |
| 07/06/2004 | US6759042 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent |
| 07/01/2004 | WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003021265A8 Genetic construct intracellular monitoring system |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | US20040127400 for inducing antibody production against Streptococcal antigens |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 06/30/2004 | EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles. |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432451A2 Production of fusion proteins and use for identifying binding molecules |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus |
| 06/30/2004 | CN1509293A Expression technology for proteins containing hybrid isotype antibody moiety |
| 06/30/2004 | CN1508253A Hybrid expression of Neisseria protein |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756478 Polypeptide for use in diagnosis and treatment of infections |
| 06/29/2004 | US6756199 Used for the synthesis of both predefined and random sequence peptide nucleic acid oligomers |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053130A1 Regulatory zinc finger proteins |
| 06/24/2004 | WO2004052930A2 Targeting single epitopes |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |